CSPC Pharmaceutical Group Limited (CVG) — Cash Flow Reinvestment Rate

Latest as of September 2020: 0.39x

CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow Reinvestment Rate of 0.39x as of September 2020, reinvesting €831.32 Million (capex €258.14 Million plus investments €-573.18 Million) from operating cash flow of €2.16 Billion. See CSPC Pharmaceutical Group Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.39x
(Capex + Investments) / Operating CF

Total Reinvested

€831.32 Million
Capex + Investments

Operating Cash Flow

€2.16 Billion
EUR

Capital Expenditures

€258.14 Million
EUR

CSPC Pharmaceutical Group Limited Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for CSPC Pharmaceutical Group Limited across 13 annual periods. For the full cash flow conversion analysis, see how efficiently does CSPC Pharmaceutical Group Limited generate cash.

Annual Cash Flow Reinvestment Rate for CSPC Pharmaceutical Group Limited (2013–2025)

Year-by-year capital reinvestment analysis for CSPC Pharmaceutical Group Limited. See CVG free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.74x €4.33 Billion €5.83 Billion €2.28 Billion ▼ -18.3%
2024 0.91x €4.12 Billion €4.53 Billion €2.68 Billion ▲ +51.9%
2023 0.60x €2.50 Billion €4.18 Billion €1.89 Billion ▼ -27.5%
2022 0.83x €6.30 Billion €7.63 Billion €2.22 Billion ▲ +87.5%
2021 0.44x €2.04 Billion €4.64 Billion €1.41 Billion ▲ +64.2%
2020 0.27x €1.81 Billion €6.74 Billion €1.36 Billion ▼ -52.7%
2019 0.57x €2.14 Billion €3.78 Billion €1.88 Billion ▼ -30.7%
2018 0.82x €3.10 Billion €3.80 Billion €1.67 Billion ▼ -7.3%
2017 0.88x €2.90 Billion €3.29 Billion €1.18 Billion ▲ +14.0%
2016 0.77x €2.25 Billion €2.92 Billion €1.06 Billion ▲ +101.0%
2015 0.38x €864.81 Million €2.25 Billion €815.69 Million ▼ -15.4%
2014 0.45x €820.58 Million €1.81 Billion €807.00 Million ▼ -40.6%
2013 0.77x €623.39 Million €814.86 Million €597.12 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow